pone.0294116.g001.tif (203.95 kB)
Timeline of the prospective study, *120 mg twice daily, **240 mg twice daily, Rx-refills.
figure
posted on 2024-03-04, 19:36 authored by Maj Jožef, Igor Locatelli, Gregor Brecl Jakob, Lina Savšek, Katarina Šurlan Popovič, Žiga Špiclin, Uroš Rot, Mitja KosTimeline of the prospective study, *120 mg twice daily, **240 mg twice daily, Rx-refills.
History
Usage metrics
Categories
Keywords
predicting medication concernsincreased number (<women ), 34medium adherent uponlower medication concerns93 -(- 033 – 00134 – 0included 40 pwmsestimating medication adherencediv >< p6 ± 9retest reliability (<establish criterion validityst 24 pwms graded6 pwmslower adherenceretest methodcriterion validitypwms selfpwms ).r p evaluating adherence9 years9 months5 ),total volumerelapse occurrenceradiological progressionquantitative analysispsychometric evaluationmultiple sclerosismedicines questionnairelt ;highly adherenthigher pdchealth outcomesdmf ).dimethyl fumaratedays coveredcronbach αbmq ).age 3779 ).579 )).0403 ))00149 ).
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC